Results 21 to 30 of about 52,877 (267)
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.
Journal of the American Medical Association (JAMA), 2021 Importance
Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinical benefit.
Objective
To determine whether ivermectin is an efficacious treatment for mild COVID-19.Eduardo López-Medina, Pio López, I. Hurtado, D. Dávalos, Oscar Ramírez, Ernesto Martínez, J. Diazgranados, J. Onate, Hector Chavarriaga, S. Herrera, B. Parra, G. Libreros, R. Jaramillo, A. C. Avendaño, D. F. Toro, M. Torres, M. C. Lesmes, Carlos A. Ríos, Isabella Caicedo +18 moresemanticscholar +1 more sourceEffect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
Journal of the American Medical Association (JAMA), 2023 Importance
It is unknown whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients with mild to moderate COVID-19.S. Naggie, D. Boulware, C. Lindsell, T. G. Stewart, Alex J. Slandzicki, S. Lim, J. Cohen, D. Kavtaradze, Arch Amon, Ahab Gabriel, N. Gentile, G. Felker, D. Jayaweera, M. McCarthy, M. Sulkowski, R. Rothman, Sybil Wilson, Allison Delong, A. Remaly, Rhonda Wilder, S. Collins, S. Dunsmore, S. Adam, F. Thicklin, George J. Hanna, A. Ginde, Mario Castro, K. McTigue, E. Shenkman, A. Hernandez, William (Kelly) Vincent, Raina Vincent, Ray Bianchi, Jen Premas, Diana Cordero-Loperena, Evelyn Rivera, Madhu Gupta, Greg Karawan, Carey Ziomek, Josephine Arena, S. DeAlmeida, Soroush Ramin, Jaya Nataraj, Michael K. Paasche-Orlow, Lori Henault, Katherine R. Waite, David Miller, Ginger Brounce, Constance George-Adebayo, Adeoluwa Adebayo, Jessica Wallan, Claudia Vogel, Sebastian Munoz, Cassandra Watson, David Singleton, Maria Rivon, Amanda Sevier, Arnold Del Pilar, Amber Spangler, Sohail Rao, Luis Cantu, Arvind Krishna, Kathy Evans, Tylene Falkner, B. Kerr, Robert Spees, M. Marta, Amanda Harrington, Rowena Dolor, Madison Frazier, Lorraine Vergara, Jessica Wilson, Valencia Burruss, Terri Hurst, Igho Ofotokun, Pauline Rebolledo, Rajesh M. Prabhu, Krystal Klicka, Amber Lightfeather, Vicki James, M. Rogers, P. Parihar, De'Ambra Torress, Chukwuemeka Oragwu, Ngozi Oguego, Rajesh Pillai, Mustafa Juma, Emad Ghaly, Dafer Al-Haddadin, Courtney Ramirez, Gammal Hassanien, Samah Ismail, A. Meltzer, Seamus Moran, Scott Brehaut, Angelina Roche, Manisha Mehta, Nicole Koppinger, Jose E. Baez, Ivone Pagan, Dallal Abdelsayed, Mina Aziz, P. Robinson, J. Nguyen, Victoria Pardue, Lisa Hammons, Juan Ruiz-Unger, Susan Gonzalez, Lionel Reyes, John Cienki, Gisselle A. Jimenez, Matthew Wong, Ying Yuan, Jenny Li, J. Szeto, Lauren Stelmash, D. Haight, Deryl Lamb, Amron Harper, Nancy Pyram-Bernard, A. Quintero, Eftim Adhami, Josette Maria, Diksha Paudel, Oksana Raymond, Jeffrey Summers, Tammy Turner, Leslie Lenert, Samuel A. Gallegos, Elizabeth Ann Szwast, Ahsan Abdulghani, Pravin Vasoya, Conrad Miller, Hawa Wiley, Nirav S. Shah, Tovah Klein, Julie Castex, Phillip Feliciano, J. Olivo, Marian Ghaly, Zainub Javed, Alexandra Nawrocki, Anthony Vecchiarelli, Nikki Vigil, Vijaya Cherukuri, Erica Burden, Dawn Linn, Laura Fisher, Vijay Patel, Praksha Patel, Yuti P. Patel, Leonard Ellison, Jeffrey Harrison, Binod Shah, Sugata Shah, U. Singh, Julie M. Donahue, Yasmin Jazayeri, Anita Gupta, N. Chandrasekar, Beth Moritz, Tabitha Fortt, Anisa Fortt, Ingrid Jones-Ince, Alix McKee, Christy Schattinger, Jason Wilson, Brenda Farlow, Lillian Finlaw, Randall Richwine, Tearani Williams, Penny Paizer, Lisa Carson, Edward Michelson, Danielle Austin, Sangeeta Khetpal, Tiffany Cantrell, Drew Franklin, Karissa Marshall, Arvind Mahadevan, Madelyn Rosequist, Martin Gnoni, Crystal Daffner, Carla VandeWeerd, M. Roberts, M. D'Andrea, Wayne Swink, Margaret Powers-Fletcher, Sylvere Mukunzi, Jamie Hensley, B. Manning, Carmen Isache, Jennifer Bowman, Angelique Callaghan-Brown, T. Scott, Tiffany Schwasinger-Schmidt, Ashlie Cornejo, Mary R. Almánzar, Letty Ginsburg, Americo Hajaz, Carolyn T. Bramante, M. Robinson, Michelle Seithel, Akira Sekikawa, Emily Klawson, Luis Ostrosky, Virginia Umana, Thomas F. Patterson, Robin Tragus, Patrick E. H. Jackson, Caroline Hallowell, Heather Haughey, Bhavna Vaidya-Tank, C. Gould, Parul Goyal, Carly Gatewood, John C. Williamson, Hannah Seagle, Elizabeth Salsgiver, Eddie Armas, Jhonsai Cheng, Priscilla Huerta, J. Garcia-Diaz, David Aamodt, JaMario Ayers, Jess Collins, J. Graves, James Grindstaff, Jessica Lai, Itzel Lopez, Jessica Marlin, A. Merkel, Sam Nwosu, Savannah Obregon, Dirk Orozco, Yoli Perez-Torres, Nelson Prato, Colleen Ratcliff, Max Rhode, Jana Shirey-Rice, Krista Vermillion, Hsi-Nien Tan, Seibert Tregoning, Meghan Vance, Amber Vongsamphanh, Maria Weir, Nicole Zaleski, Samuel Bozzette, Gene Passamani +248 moresemanticscholar +1 more sourceRandomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
New England Journal of Medicine, 2022 BACKGROUND Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.C. Bramante, Jared D. Huling, Christopher J. Tignanelli, J. Buse, D. Liebovitz, J. Nicklas, Kenneth Cohen, M. Puskarich, H. Belani, Jennifer L. Proper, L. Siegel, N. Klatt, D. Odde, Darlette G. Luke, Blake Anderson, Amy B. Karger, N. Ingraham, Katrina M. Hartman, Via Rao, Aubrey A. Hagen, Barkha P. Patel, S. Fenno, N. Avula, Neha V. Reddy, S. Erickson, S. Lindberg, R. Fricton, Samuel Lee, A. Zaman, Hanna G Saveraid, Walker J Tordsen, Matthew F. Pullen, M. Biros, Nancy E. Sherwood, Jennifer L. Thompson, D. Boulware, Thomas A. Murray +36 moresemanticscholar +1 more sourceThe effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
EClinicalMedicine, 2021 Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients.Carlos J. Chaccour, A. Casellas, Andrés Blanco-Di Matteo, Íñigo Pineda, A. Fernández-Montero, Paula Ruiz-Castillo, M. Richardson, Mariano Rodríguez-Mateos, Carlota Jordán-Iborra, J. Brew, Francisco Carmona-Torre, M. Giráldez, E. Laso, J. Gabaldón-Figueira, C. Dobaño, Gemma Moncunill, J. Yuste, J. D. del Pozo, N. Rabinovich, Verena Schöning, F. Hammann, G. Reina, B. Sádaba, M. Fernández-Alonso +23 moresemanticscholar +1 more sourceIvermectin for preventing and treating COVID‐19
Cochrane Database of Systematic Reviews, 2021 Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of action suggests an inhibitory effect on severe acute respiratory ...Maria Popp, M. Stegemann, M. Metzendorf, Susan Gould, P. Kranke, P. Meybohm, N. Skoetz, S. Weibel +7 moresemanticscholar +1 more sourceIvermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
American Journal of Therapeutics, 2021 Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.A. Bryant, Theresa A Lawrie, T. Dowswell, E. Fordham, S. Mitchell, Sarah Hill, T. Tham +6 moresemanticscholar +1 more source